News Releases | Insmed Incorporated

Month Year

Email Alerts

Aug 6, 2012

Pharmaceutical Industry Veteran Al Altomari Elected To Insmed's Board Of Directors

Read more
Aug 2, 2012

Insmed Receives Second Composition Of Matter Patent For ARIKACE®

Read more
Jul 30, 2012

Insmed Announces Planned Departure Of Chief Financial Officer

Read more
Jul 24, 2012

Insmed to Host 2012 Second Quarter Earnings Conference Call

Read more
Jul 10, 2012

Insmed To Present At JMP Securities 7th Annual Healthcare Conference

Read more
Jul 2, 2012

Insmed Secures $20 Million Loan Agreement With Hercules Technology Growth Capital

Read more
Jun 27, 2012

Insmed Announces First Patient Dosed in TARGET-NTM Phase 2 Clinical Trial of ARIKACE® in Patients with Non-Tuberculous Mycobacteria (NTM) Lung Disease

Read more
May 30, 2012

Insmed Provides Corporate Update

Read more
May 23, 2012

Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease

Read more
May 16, 2012

Insmed Appoints Donald J. Hayden, Jr. as Executive Chairman

Read more
May 8, 2012

Insmed Announces First Quarter 2012 Financial Results

Read more
May 7, 2012

Insmed Incorporated Announces Lifting of Clinical Hold by U.S. Food and Drug Administration on ARIKACE® in Cystic Fibrosis Patients With Pseudomonas Lung Infections

Read more
Apr 24, 2012

Insmed to Host 2012 First Quarter Earnings Conference Call

Read more
Apr 16, 2012

Insmed Announces First Patient Dosed in Pivotal European Phase 3 Clinical Study of ARIKACE® in Cystic Fibrosis Patients with Pseudomonas Lung Infections

Read more
Mar 13, 2012

Insmed Announces Fourth Quarter and Full-Year 2011 Financial Results

Read more
Feb 28, 2012

Insmed to Host Fourth Quarter and 2011 Year-End Earnings Conference Call

Read more
Feb 10, 2012

Insmed Incorporated Provides Update on Clinical Program for ARIKACE®

Read more
Jan 20, 2012

Insmed Incorporated Provides Corporate Update

Read more
Nov 14, 2011

Insmed to Present at Lazard Capital Markets 8th Annual Healthcare Conference

Read more
Nov 8, 2011

Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2011

Read more
Oct 25, 2011

Insmed to Host 2011 Third Quarter Earnings Conference Call

Read more
Oct 24, 2011

Insmed Incorporated Provides Regulatory Update on ARIKACE® in Non-Tuberculous Mycobacteria Indication

Read more
Oct 10, 2011

Insmed Incorporated Provides Regulatory Update

Read more
Sep 26, 2011

Insmed to Present at Sixth Annual JMP Securities Healthcare Conference

Read more
Aug 11, 2011

Insmed to Present at 2011 Wedbush Securities Life Sciences Management Access Conference

Read more
Aug 8, 2011

Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2011

Read more
Aug 1, 2011

Insmed Incorporated Announces Clinical Hold on ARIKACE® Phase 3 Clinical Trials

Read more
Jul 26, 2011

Insmed to Host 2011 Second Quarter Earnings Conference Call

Read more
Jul 18, 2011

Andrea Drucker Joins Insmed as General Counsel

Read more
Jun 28, 2011

Insmed Announces its Addition to the Russell 3000® Index

Read more
Jun 10, 2011

Insmed's ARIKACE® Demonstrates Sustained Benefit Through Six Cycles of Treatment for Cystic Fibrosis Patients With Pseudomonas Lung Infections

Read more
May 10, 2011

Insmed Announces First Quarter 2011 Financial Results

Insmed Announces First Quarter 2011 Financial Results

Read more
Apr 26, 2011

Insmed to Host 2011 First Quarter Earnings Conference Call

Insmed to Host 2011 First Quarter Earnings Conference Call

Read more
Mar 21, 2011

Insmed Regains NASDAQ Compliance

Read more
Mar 21, 2011

Insmed Announces FDA Clearance of IND for Pivotal Phase 3 Trial of ARIKACE™ in Nontuberculous Mycobacteria Indication

Read more
Mar 10, 2011

Insmed Announces Fourth Quarter and Full-Year 2010 Financial Results

Read more
Mar 3, 2011

Insmed Announces European Medicines Agency Acceptance of Its Pediatric Investigation Plan for ARIKACE™ in the Cystic Fibrosis Pseudomonas Indication

Read more
Mar 2, 2011

One-for-10 Reverse Stock Split of Insmed Common Stock Becomes Effective

Read more
Mar 1, 2011

Insmed Shareholders Approve Conversion of Series B Conditional Convertible Preferred Stock and Reverse Stock Split

Read more
Feb 24, 2011

Insmed to Participate on Phase III and Beyond Panel at 2011 RBC Capital Markets Healthcare Conference

Read more
Feb 23, 2011

Insmed to Host Fourth Quarter and 2010 Year-End Earnings Conference Call

Read more
Dec 16, 2010

NASDAQ Grants Insmed Incorporated 180-Day Extension to Regain Compliance with Minimum Bid Price Rule

Read more
Dec 2, 2010

Insmed Incorporated and Transave, Inc. Announce Business Combination

Read more
Nov 3, 2010

Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2010

Read more
Oct 26, 2010

Insmed to Host Third Quarter 2010 Conference Call

Read more
Aug 4, 2010

Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2010

Read more
Jul 28, 2010

Insmed to Host Second Quarter 2010 Conference Call

Read more
Jun 21, 2010

Insmed Receives NASDAQ Deficiency Notice Relating to Minimum Bid Price

Read more
May 6, 2010

Insmed Announces First Quarter 2010 Financial Results

Read more
Apr 22, 2010

Insmed to Host First Quarter 2010 Conference Call

Read more

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your email alerts.

Investor Presentation

View the latest Insmed Investor Presentation

Download

Company

Our Global Company

Patients

Current Clinical Trials

Science

Therapies

Responsibility

Responsibility in Action

Press Releases

Company

Our Global Company

Patients

Current Clinical Trials

Science

Therapies

Responsibility

Responsibility in Action

Footer